BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37013204)

  • 1. Screening HIV associated neurocognitive disorders using international HIV dementia scale: closing the gap through an educational intervention for healthcare workers.
    Namagga JK; Nambozi G; Rukundo GZ; Niyonzima V; Batwala V
    Pan Afr Med J; 2023; 44():17. PubMed ID: 37013204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare Workers' Perspectives on the Utilization of the International HIV Dementia Scale for the Screening HIV-Associated Neurocognitive Disorders: A Qualitative Study at TASO Centres in Central and Southwestern Uganda.
    Namagga JK; Rukundo GZ; Batwala V; Niyonzima V; Nantongo H; Nambozi G
    HIV AIDS (Auckl); 2024; 16():229-243. PubMed ID: 38827783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Risk Factors of HIV-Associated Neurocognitive Disorders in Rural Southwestern Uganda.
    Namagga JK; Rukundo GZ; Voss JG
    J Assoc Nurses AIDS Care; 2019; 30(5):531-538. PubMed ID: 31461736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
    Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
    PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for HIV-Associated Neurocognitive Disorder (HAND) in Adults Aged 50 and Over Attending a Government HIV Clinic in Kilimanjaro, Tanzania. Comparison of the International HIV Dementia Scale (IHDS) and IDEA Six Item Dementia Screen.
    Kellett-Wright J; Flatt A; Eaton P; Urasa S; Howlett W; Dekker M; Kisoli A; Duijinmaijer A; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska E; Akinyemi R; Lwezuala B; Gray WK; Walker RW; Dotchin CL; Makupa P; Paddick SM
    AIDS Behav; 2021 Feb; 25(2):542-553. PubMed ID: 32875460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.
    Molinaro M; Sacktor N; Nakigozi G; Anok A; Batte J; Kisakye A; Myanja R; Nakasujja N; Robertson KR; Gray RH; Wawer MJ; Saylor D
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):278-283. PubMed ID: 32032278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normative scores for select neuropsychological battery tests for the detection of HIV-associated neurocognitive disorder amongst Nigerians.
    Nweke M; Mshunqane N; Govender N; Akinpelu AO; Ogunniyi A
    Niger Postgrad Med J; 2022; 29(3):262-267. PubMed ID: 35900464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
    Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
    BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of the HIV dementia scale and the international HIV dementia scale in screening for HIV-associated neurocognitive disorders among Spanish-speaking adults.
    López E; Steiner AJ; Smith K; Thaler NS; Hardy DJ; Levine AJ; Al-Kharafi HT; Yamakawa C; Goodkin K
    Appl Neuropsychol Adult; 2017; 24(6):512-521. PubMed ID: 27712132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
    Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
    Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
    Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
    AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive Disorders in HIV-positive Patients.
    Padole PS; Padhiyar RN; Yadav DS; Chavan SA
    J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the International HIV Dementia Scale in South Africa.
    Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
    AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression and HIV associated neurocognitive disorders among HIV infected adults in rural southwestern Uganda: a cross-sectional quantitative study.
    Namagga JK; Rukundo GZ; Niyonzima V; Voss J
    BMC Psychiatry; 2021 Jul; 21(1):350. PubMed ID: 34253176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
    Nyundo AA
    PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection.
    Lopardo GD; Bissio E; Iannella Mdel C; Crespo AD; Garone DB; Cassetti LI
    J Acquir Immune Defic Syndr; 2009 Dec; 52(4):488-92. PubMed ID: 19654553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.
    Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC
    AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of the International HIV Dementia Scale in the current era.
    Milanini B; Paul R; Bahemana E; Adamu Y; Kiweewa F; Langat R; Owuoth J; Allen E; Polyak C; Ake J; Valcour V;
    AIDS; 2018 Nov; 32(17):2477-2483. PubMed ID: 30134293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting.
    Robbins RN; Remien RH; Mellins CA; Joska JA; Stein DJ
    AIDS Patient Care STDS; 2011 Oct; 25(10):587-93. PubMed ID: 21919734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.